PL3768248T3 - Stała tabletka farmaceutyczna - Google Patents

Stała tabletka farmaceutyczna

Info

Publication number
PL3768248T3
PL3768248T3 PL19714544.4T PL19714544T PL3768248T3 PL 3768248 T3 PL3768248 T3 PL 3768248T3 PL 19714544 T PL19714544 T PL 19714544T PL 3768248 T3 PL3768248 T3 PL 3768248T3
Authority
PL
Poland
Prior art keywords
solid pharmaceutical
pharmaceutical tablet
tablet
solid
pharmaceutical
Prior art date
Application number
PL19714544.4T
Other languages
English (en)
Inventor
Jesper Neergaard
Original Assignee
Fertin Pharma A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fertin Pharma A/S filed Critical Fertin Pharma A/S
Publication of PL3768248T3 publication Critical patent/PL3768248T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058Chewing gums
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL19714544.4T 2018-03-23 2019-03-21 Stała tabletka farmaceutyczna PL3768248T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/933,942 US10980831B2 (en) 2018-03-23 2018-03-23 Solid pharmaceutical tablet
PCT/DK2019/050100 WO2019179589A1 (en) 2018-03-23 2019-03-21 A solid pharmaceutical tablet

Publications (1)

Publication Number Publication Date
PL3768248T3 true PL3768248T3 (pl) 2023-08-28

Family

ID=65995450

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19714544.4T PL3768248T3 (pl) 2018-03-23 2019-03-21 Stała tabletka farmaceutyczna

Country Status (10)

Country Link
US (3) US10980831B2 (pl)
EP (2) EP3831368A1 (pl)
JP (1) JP7303211B2 (pl)
CN (1) CN111902135A (pl)
AU (2) AU2019239514B2 (pl)
BR (1) BR112020018025A2 (pl)
CA (1) CA3094737A1 (pl)
ES (1) ES2951267T3 (pl)
PL (1) PL3768248T3 (pl)
WO (1) WO2019179589A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025230986A1 (en) * 2024-04-29 2025-11-06 Anju Majeed Aqueous dispersion of molecules-process, formulation and method thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327076A (en) * 1980-11-17 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same
US4753805A (en) 1984-01-31 1988-06-28 Warner-Lambert Company Tabletted chewing gum composition and method of preparation
ZA87994B (en) 1986-02-27 1987-09-30 Warner Lambert Co Antacid chewing gum
JPH0695888B2 (ja) 1989-10-18 1994-11-30 株式会社サンギ カルシウム補給用チューインガム
US5637313A (en) 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
RU2226060C2 (ru) 1999-04-15 2004-03-27 Вм.Ригли Дж.Компани Не содержащая сахара жевательная резинка для реминерализации зубной эмали (варианты) и способ реминерализации зубов
US7244455B2 (en) 2002-01-16 2007-07-17 Warner-Lambert Company Center-filled chewing gum containing a deliverable form of calcium
EP1495680A1 (en) 2003-07-08 2005-01-12 Gum Base Co. S.p.A. Gum base for chewing gum
CA2578595C (en) * 2004-06-29 2013-02-19 Fertin Pharma A/S Tobacco alkaloid releasing chewing gum
ATE418328T1 (de) 2004-07-06 2009-01-15 Gumlink As Komprimierte kaugummitablette
US8765178B2 (en) 2006-07-19 2014-07-01 Watson Laboratories, Inc. Controlled release formulations and associated methods
AU2008220845B2 (en) 2007-02-26 2013-10-03 Revolymer Limited Medicated chewing gum
WO2015070875A1 (en) 2013-11-15 2015-05-21 Fertin Pharma A/S Chewing gum suitable for diabetics
JP6682450B2 (ja) 2014-04-08 2020-04-15 フェルティン ファルマ アー/エス 医療用チューインガム
GB2542192A (en) * 2015-09-11 2017-03-15 Revolymer (Uk) Ltd Chewable medicament
WO2017059858A1 (en) 2015-10-07 2017-04-13 Fertin Pharma A/S Chewing gum comprising nicotine
ITUA20163230A1 (it) 2016-05-06 2017-11-06 Perfetti Van Melle Spa Gomma da masticare con stevia
US10933017B2 (en) 2019-03-01 2021-03-02 Nordiccan A/S Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers

Also Published As

Publication number Publication date
EP3768248B1 (en) 2023-06-14
US20210205355A1 (en) 2021-07-08
EP3768248C0 (en) 2023-06-14
US11730757B2 (en) 2023-08-22
JP2021518412A (ja) 2021-08-02
US20210023128A1 (en) 2021-01-28
JP7303211B2 (ja) 2023-07-04
EP3831368A1 (en) 2021-06-09
EP3768248A1 (en) 2021-01-27
WO2019179589A1 (en) 2019-09-26
US11723918B2 (en) 2023-08-15
AU2019239514B2 (en) 2024-02-01
US20190290684A1 (en) 2019-09-26
CN111902135A (zh) 2020-11-06
BR112020018025A2 (pt) 2020-12-22
CA3094737A1 (en) 2019-09-26
US10980831B2 (en) 2021-04-20
ES2951267T3 (es) 2023-10-19
AU2019239514A1 (en) 2020-10-29
AU2024202892A1 (en) 2024-05-23
AU2024202892B2 (en) 2025-01-16

Similar Documents

Publication Publication Date Title
GB2572126B (en) Pharmaceutical
GB2569961B (en) Pharmaceutical
GB2572125B (en) Pharmaceutical
SI3529248T1 (sl) Farmacevtske spojine
DK3655017T3 (da) Farmaceutisk sammensætning
EP3689892A4 (en) RADIOACTIVE MEDICINAL PRODUCT
EP3603642A4 (en) PHARMACEUTICAL PREPARATION
DK3529240T3 (da) Farmaceutiske forbindelser
DK3634377T3 (da) Farmaceutisk formulering
IL283900A (en) Pharmaceutical combinations
EP3756639C0 (en) TABLET CASSETTE
EP3449912A4 (en) MELTING TABLET
DK3583943T3 (da) Farmaceutisk sammensætning
EP3486117A4 (en) TABLE UNIT
EP3646866A4 (en) PHARMACEUTICAL PREPARATION
EP3881897A4 (en) LAXATIVE IN TABLET FORM
DK3728220T3 (da) Farmaceutiske forbindelser
PL3694522T3 (pl) Dwuwarstwowa formulacja tabletki farmaceutycznej
HUE069648T2 (hu) Gyógyszerészeti készítmény
DK3432887T3 (da) Anti-tuberkulosemiddel
EP3727485C0 (en) PHARMACEUTICAL COMPOSITION
EP3646865A4 (en) MEDICINE
EP3590513A4 (en) DRUG
DK3601277T3 (da) Farmaceutisk formulering
PL3965739T3 (pl) Postacie dawkowane będące tabletkami oleilofosfocholiny